在线血液透析滤过与常规血液透析在危重症患者中的比较
单中心回顾性队列研究纳入2017至2020年182例在ICU启动间歇性肾脏替代治疗的急性肾损伤成人,比较在线血液透析滤过(HDF)与常规血液透析(HD)。HDF与90天死亡率、肾脏恢复及透析中低血压无显著关联,但与后续升压药使用减少和首疗程后中性粒细胞与淋巴细胞比值(NLR)降幅更大相关,同时滤器血栓风险增加。
核心结论
- 在急性肾损伤(AKI)患者中使用在线血液透析滤过(HDF)与死亡或肾脏恢复风险无差异。
研究设计与样本
- 单中心回顾性队列研究,使用2017年至2020年数据,纳入182例在ICU启动间歇性肾脏替代治疗(IRRT)的AKI成人,共完成848次IRRT治疗。
- 使用HDF或血液透析(HD)取决于水系统维护状态而不考虑患者特征;分别采用时间依赖Cox模型和广义估计方程模型评估患者事件和治疗事件的相关性。
主要发现
- 90天死亡率为43/182(24.6%)。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
INTRODUCTION: Online hemodiafiltration (HDF) has been increasingly used for improved clearance of middle molecular weight toxins. The impact of this mode of clearance is unknown in critically ill patients. We aimed to determine whether the use of HDF in acute kidney injury (AKI) is associated with lower mortality and improved kidney recovery up to 90 days after initiation of therapy. METHODS: Single-center retrospective cohort study using data from 2017 to 2020 of adults with AKI who initiated intermittent renal replacement therapy (IRRT) in the intensive care unit (ICU), using either hemodialysis (HD) or HDF depending on the maintenance status of the water system without regards for patient characteristics. We assessed association with patient-events and session-events using time-dependent Cox models and general estimating equations models, respectively. RESULTS: We included 182 adults with AKI for whom 848 IRRT sessions were performed in the ICU. The 90-day mortality rate was 43 of 182 (24.6%). There was no significant association with the use of HDF and mortality (adjusted hazard ratio [aHR]: 0.85 (0.43; 1.67) P = 0.64), kidney recovery (aHR: 1.18 (0.76; 1.84) P = 0.47), or intradialytic hypotension (adjusted odds ratio [aOR]: 0.91 confidence interval [CI]: 0.64-1.28 P = 0.58). HDF treatment was associated with a lower rate of subsequent vasopressor use (aOR: 0.60 CI: 0.36-0.99 P = 0.047) and a greater reduction of the neutrophil-to-lymphocyte ratio (NLR) following the first session (-15.0% vs. +5.1%, P = 0.047) but was also associated with increased risk of filter thrombosis during treatment (aOR: 2.42 CI: 1.67-3.50 P < 0.001). CONCLUSION: The use of HDF in the setting of AKI was not associated with a differential risk of mortality or kidney recovery.
引用
- Piotte J, Louis F, Buyansky D, et al. Online Hemodiafiltration Compared to Conventional Hemodialysis in Critically Ill Patients. Kidney Int Rep. 2022. PMID: 36531895. doi:10.1016/j.ekir.2022.08.007
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。